Involvement of mature donor T cells in the NK cell reconstitution after haploidentical hematopoietic stem-cell transplantation

被引:0
作者
S Nguyen
M Kuentz
J-P Vernant
N Dhedin
D Bories
P Debré
V Vieillard
机构
[1] Laboratoire d'Immunologie Cellulaire et Tissulaire,
[2] Institut National de la Santé et de la Recherche Médicale (INSERM) U543,undefined
[3] Hôpital Pitié-Salpêtrière,undefined
[4] Service d'Hématologie Clinique,undefined
[5] Hôpital Pitié-Salpêtrière,undefined
[6] Service d'Hématologie Clinique,undefined
[7] Hôpital Henri Mondor,undefined
[8] Service d'Hématologie,undefined
[9] Hôpital Henri Mondor,undefined
来源
Leukemia | 2008年 / 22卷
关键词
NK cells; haploidentical stem-cell transplantation; mature T cells; NKG2A; cytotoxicity;
D O I
暂无
中图分类号
学科分类号
摘要
We previously demonstrated that natural killer (NK) cells generated after haploidentical stem-cell transplantation (SCT) are blocked at an immature state characterized by phenotypic features and impaired functioning and that this may affect transplantation outcome. We hypothesize that the absence of mature donor T cells in the graft may affect NK cell differentiation. NK cells from 21 transplant recipients who underwent either partial (pTCD; n=11) or extensive (eTCD; n=10) T-cell depletion were compared with NK cells from their healthy donors. We report that despite the strong graft-versus-host disease (GvHD) reaction, pTCD patients, with T cells present during SCT, had a better clinical outcome than patients with eTCD transplants. In addition, the frequency of CD3−CD56bright and NKG2A+ NK cells was much lower in pTCD than in eTCD patients after transplantation, and the level of cytotoxicity against primary haplo-mismatched blasts was significantly more pronounced after pTCD than eTCD transplants. These finding strongly suggest that mature donor T cells in the graft may play a key role in NK cell differentiation in vivo, after haploidentical SCT.
引用
收藏
页码:344 / 352
页数:8
相关论文
共 212 条
[1]  
Moretta L(2004)Unravelling natural killer cell function: triggering and inhibitory human NK receptors EMBO J 23 255-259
[2]  
Moretta A(2007)NK cell recognition Annu Rev Immunol 23 225-274
[3]  
Lanier LL(1997)Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors Immunity 7 739-751
[4]  
Valiante NM(1999)Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation Blood 94 333-339
[5]  
Uhrberg M(2002)Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants Science 295 2097-2100
[6]  
Shilling HG(2005)The impact of donor natural killer cell alloreactivity on allogeneic hematopoietic transplantation Transpl Immunol 14 203-206
[7]  
Lienert-Weidenbach K(2003)Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors Blood 102 814-819
[8]  
Arnett KL(2002)Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor Blood 100 3825-3827
[9]  
D'Andrea A(2004)Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donors Blood 103 2860-2861
[10]  
Ruggeri L(2004)The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD Tissue Antigens 63 204-211